These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 866702)

  • 21. Prostaglandin E2-induced release of luteinizing hormone-releasing factor (LRF).
    Ojeda SR; Wheaton JE; McCann SM
    Neuroendocrinology; 1975; 17(3):283-7. PubMed ID: 1095952
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Somatostatin prevents the desensitizing action of growth hormone-releasing factor on growth hormone release.
    Simard J; Lefèvre G; Labrie F
    Peptides; 1987; 8(2):199-205. PubMed ID: 2884644
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neuropeptide Y levels in microdissected regions of the hypothalamus and in vitro release in response to KCl and prostaglandin E2: effects of castration.
    Sahu A; Kalra SP; Crowley WR; O'Donohue TL; Kalra PS
    Endocrinology; 1987 May; 120(5):1831-6. PubMed ID: 3552624
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Atrial natriuretic factor inhibits luteinizing hormone secretion in the rat: evidence for a hypothalamic site of action.
    Samson WK; Aguila MC; Bianchi R
    Endocrinology; 1988 Apr; 122(4):1573-82. PubMed ID: 2964365
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The reduction of circulating growth hormone and prolactin in streptozocin-induced diabetic male rats is possibly caused by hypothalamic rather than pituitary changes.
    Boujon CE; Bestetti GE; Abramo F; Locatelli V; Rossi GL
    J Endocrinol; 1995 Apr; 145(1):19-26. PubMed ID: 7798026
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of age on prostaglandin E2 stimulation of growth hormone release from cultured rat pituitary cells.
    Cuttler L; Birkenbach PA; Szabo M
    Endocrinology; 1989 Feb; 124(2):661-6. PubMed ID: 2912693
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The stimulatory effect on gonadotropin release of implants of estradiol or progesterone in certain sites in the central nervous system.
    Kalra PS; McCann SM
    Neuroendocrinology; 1975; 19(4):289-302. PubMed ID: 1226226
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intrahypothalamic action of corticotrophin-releasing factor (CRF) to inhibit growth hormone and LH release in the rat.
    Ono N; Lumpkin MD; Samson WK; McDonald JK; McCann SM
    Life Sci; 1984 Sep; 35(10):1117-23. PubMed ID: 6090831
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Growth hormone releasing activity persists in the deafferented medial-basal hypothalamus of the rat.
    Antoni FA; Makara GB; Rappay G
    J Endocrinol; 1981 Dec; 91(3):415-25. PubMed ID: 6120201
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cysteamine-induced enhancement of growth hormone-releasing factor (GRF) immunoreactivity in arcuate neurons: morphological evidence for putative somatostatin/GRF interactions within hypothalamus.
    Tannenbaum GS; McCarthy GF; Zeitler P; Beaudet A
    Endocrinology; 1990 Nov; 127(5):2551-60. PubMed ID: 1977581
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of intravenous and intraventricular injection of antisera directed against corticotropin-releasing factor on the secretion of anterior pituitary hormones.
    Ono N; Samson WK; McDonald JK; Lumpkin MD; Bedran de Castro JC; McCann SM
    Proc Natl Acad Sci U S A; 1985 Nov; 82(22):7787-90. PubMed ID: 2999777
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of central injection of bradykinin and bradykinin potentiating factor upon release of anterior pituitary hormones in ovariectomized female rats.
    Steele MK; Negro-Vilar A; McCann SM
    Peptides; 1980; 1(3):201-5. PubMed ID: 6785730
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Galanin: evidence for a hypothalamic site of action to release growth hormone.
    Ottlecz A; Samson WK; McCann SM
    Peptides; 1986; 7(1):51-3. PubMed ID: 2423991
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stimulation of growth hormone release by luteinizing hormone-releasing hormone and melanocyte-stimulating hormone-release inhibiting hormone in the hypophysectomized rat bearing an ectopic pituitary.
    Panerai AE; Cocchi D; Gil-ad I; Locatelli V; Rossi GL; Múller EE
    Clin Endocrinol (Oxf); 1976 Nov; 5(6):717-22. PubMed ID: 12896
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Control of growth hormone release by growth hormone-releasing factor and prostaglandin E2 in a system of perfused rat anterior pituitary cells].
    Fafeur V; Tiberghien C; Haour F; Dray F
    Reprod Nutr Dev (1980); 1988; 28(2A):229-31. PubMed ID: 3131855
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Studies of growth hormone secretion VIII. Effects of alpha,beta-methylene-ATP on prostglandin induced GH release and cyclic AMP accumlation in rat anterior pituitary glands.
    Hertelendy F; Yeh M
    Prostaglandins; 1976 Feb; 11(2):285-91. PubMed ID: 178028
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Growth hormone releasing effect of hpGRF-40 in rats at different time intervals following ablation of the mediobasal hypothalamus.
    Locatelli V; Cella SG; Loche S; Pintor C; Müller EE
    Life Sci; 1984 Nov; 35(19):1989-95. PubMed ID: 6436609
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Progesterone augments copper-prostaglandin E2 stimulation of the release of gonadotropin-releasing hormone from explants of the median eminence of immature female rats: an estrogen-dependent process.
    Bhasker KR; Barnea A
    Endocrinology; 1988 May; 122(5):2143-9. PubMed ID: 3282877
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pituitary-dependent hormonal regulation of galaninergic neurons in the rat hypothalamus.
    Selvais PL; Adam E; Colin IM; Kasa-Vubu JZ; Denef JF; Maiter DM
    Neuroendocrinology; 1994 Oct; 60(4):368-77. PubMed ID: 7529898
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Blockade of growth hormone-releasing factor (GRF) activity in the pituitary and hypothalamus of the conscious rat with a peptidic GRF antagonist.
    Lumpkin MD; McDonald JK
    Endocrinology; 1989 Mar; 124(3):1522-31. PubMed ID: 2537185
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.